Dose-response assessment of tariquidar for inhibition of P-glycoprotein at the human blood-brain barrier using (R)-[11C]verapamil PET

From: 16th Scientific Symposium of the Austrian Pharmacological Society (APHAR) Vienna, Austria 25-27 November 2010 Author details 1-Department of Clinical Pharmacology, Medical University of Vienna, 1090 Vienna, Austria EMPTY 2-Department of Nuclear Medicine, Medical University of Vienna, 1090 Vien...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC pharmacology 2010-11, Vol.10 (S1), p.A47-A47, Article A47
Hauptverfasser: Bauer, Martin, Zeitlinger, Markus, Matzneller, Peter, Stanek, Johann, Lackner, Edith, Wadsak, Wolfgang, Müller, Markus, Langer, Oliver
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:From: 16th Scientific Symposium of the Austrian Pharmacological Society (APHAR) Vienna, Austria 25-27 November 2010 Author details 1-Department of Clinical Pharmacology, Medical University of Vienna, 1090 Vienna, Austria EMPTY 2-Department of Nuclear Medicine, Medical University of Vienna, 1090 Vienna, Austria EMPTY 3-Health and Environment Department, Molecular Medicine, AIT Austrian Institute of Technology GmbH, 2444 Seibersdorf, AustriaEMPTY Supplemental Information:
ISSN:1471-2210
1471-2210
DOI:10.1186/1471-2210-10-S1-A47